Litigation Details for LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-01-02 |
| Court | District Court, D. Delaware | Date Terminated | 2019-10-17 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Parties | FOAMIX PHARMACEUTICALS LTD. | ||
| Patents | 10,117,812; 7,700,076; 8,435,498; 8,722,021; 8,900,554; 9,211,259; 9,265,725 | ||
| Attorneys | Marta M. Chlistunoff | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Biologic Drugs cited in LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-02 | 1 | of U.S. Patent No. 7,700,076 (“the ’076 patent”), U.S. Patent No. 8,435,498 (“the ’498 patent”), U.S.… COUNT I – INFRINGEMENT OF U.S. PATENT NO. 7,700,076 24. Plaintiffs fully incorporate…076 patent, the ’498 patent, the ’021 patent, the ’554 patent, the ’259 patent, or the ’725 patent, respectively…076 patent, the ’498 patent, the ’021 patent, the ’554 patent, the ’259 patent, or the ’725 patent, prior… of the ’076 patent, the ’498 patent, the ’021 patent, the ’554 patent, the ’259 patent, and the ’725 | External link to document | |
| 2019-10-17 | 137 | Patent/Trademark Report to Commissioner of Patents | B2 ;8,900,554 B2 ;9,211,259 B2 ;9,265,725 B2 ;10,117,812 B2. (Attachments: # 1 Dismissal Order)(nmf) (… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,700,076 B2 ;…2018 17 October 2019 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2018-01-02 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,700,076 B2; 8,435,498 B2; 8,722,021…2018 17 October 2019 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2018-12-17 | 67 | infringement of United States Patent No. 10,117,812 (“the ’812 patent”) (Exhibit A), arising from the…infringed U.S. Patent No. 7,700,076 (“the ’076 patent”), U.S. Patent No. 8,435,498 (“the ’498 patent”), U.S.…U.S. Patent No. 8,722,021 (“the ’021 patent”), U.S. Patent No. 8,900,554 (“the ’554 patent”), U.S. Patent… The ’812 patent is from the same patent family as the Related Patents. The ’812 patent and the Related…9,211,259 (“the ’259 patent”), and U.S. Patent No. 9,265,725 (“the ’725 patent”) (collectively, “the | External link to document | |
| 2018-12-18 | 68 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,117,812 B2 . (Smith, Rodger…2018 17 October 2019 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2019-01-02 | 71 | Initial Invalidity Contentions Regarding U.S. Patent No. 10,117,812 filed by Perrigo UK FINCO Limited Partnership…2018 17 October 2019 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2019-01-06 | 72 | Identification of Claim Term(s) From U. S. Patent No. 10,117,812 filed by Perrigo UK FINCO Limited Partnership…2018 17 October 2019 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
